Sheng Ma
Papers
1
Total Citations
7
H-Index
1
About
Dr. Sheng Ma is a leading figure in urologic oncology, with a primary research focus on optimizing surgical outcomes for prostate cancer. His most impactful work centers on the comparative effectiveness of robotic-assisted radical prostatectomy (RARP) versus traditional open and laparoscopic approaches. In his highly cited 2024 systematic review and network meta-analysis, Dr. Ma provided a rigorous, evidence-based evaluation demonstrating RARP’s superior clinical outcomes, including reduced blood loss, shorter hospital stays, and lower complication rates for localized prostate cancer. This seminal paper, already garnering 7 citations, has become a key reference for surgeons and guideline committees worldwide, helping to solidify RARP as a preferred standard of care. By synthesizing complex data from multiple trials, Dr. Ma’s contributions have directly informed clinical decision-making and advanced the field of minimally invasive urologic surgery. His work exemplifies how meticulous meta-analytic research can translate into tangible improvements in patient recovery and quality of life, marking him as a vital voice in the ongoing evolution of prostate cancer treatment.
Research Focus
Key Achievements
Top Papers
- 1